Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 3, 2003, Pages 221-225

  Lövestam Adrian, Monica ^a   Agardh, Carl David ^a   Torffvit, Ole ^a   Agardh, Elisabet ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Panretinal photocoagulation; Severe non proliferative proliferative retinopathy; Type 1 diabetes; Vitrectomy; Vitreous haemorrhage

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; BLINDNESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MAJOR CLINICAL STUDY; METABOLIC REGULATION; NEOVASCULARIZATION (PATHOLOGY); ONSET AGE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

ADOLESCENT; AGE OF ONSET; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; VISION DISORDERS; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 0038420704     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00050.x     Document Type: Article

References (22)

1. Buckley S, Jenkins L&Benjamin L (1992): Field loss after panretinal photocoagulation with diode and argon lasers. Doc Ophthalmol 82: 317-322.
2. Davis MD, Fisher MR&Gangnon RE et al. (1998): Risk factors for high risk proliferative diabetic retinopathy and severe visual loss. Early Treatment Diabetic Retinopathy Study, Report No. 18. Invest Ophthalmol Vis Sci 39: 233-252.
3. Diabetic Retinopathy Study Research Group (1978): Photocoagulation treatment of proliferative diabetic retinopathy. DRS Report No. 2. Ophthalmology 85: 82-106.
4. Diabetic Retinopathy Study Research Group (1981): Photocoagulation treatment of proliferative diabetic retinopathy: clinical applications of Diabetic Retinopathy Study (DRS) findings. DRS Report No. 8. Ophthalmology 88: 583-600.
5. Early Treatment Diabetic Retinopathy Study Research Group (1985): Photocoagulation for diabetic macular oedema. ETDRS Report No. 1. Arch Ophthalmol 103: 1796-1806.
6. Early Treatment Diabetic Retinopathy Study Research Group (1991a): Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 98: 766-785.
7. Early Treatment Diabetic Retinopathy Study Research Group (1991b): Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report No. 12. Ophthalmology 98: 823-833.
8. Early Treatment Diabetic Retinopathy Study Research Group (1999): Causes of severe visual loss in the Early Treatment Diabetic Retinopathy Study. ETDRS Report No. 24. Am J Ophthalmol 127: 137-141.
9. Ferris F (1996): Early photocoagulation in patients with either type 1 or type 2 diabetes. Trans Am Ophthalmol Soc 94: 505-537.
10. Frank RN (1975): Visual field and electroretinography following extensive photocoagulation. Arch Ophthalmol 93: 591-598.
11. Jacobson AM, Rand LI&Hauser ST (1985): Psychological stress and glycaemic control: a comparison of patients with and without proliferative diabetic retinopathy. Psychosom Med 47: 372-381.
12. Klein R, Klein BEK, Moss SE&Cruickshank KJ (1994a): Relationship of hyperglycaemia to the longterm incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169-2178.
13. Klein R, Klein BEK, Moss SE&Cruickshank KJ (1994b): The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112: 1217-1228.
14. Klein R, Klein BEK, Moss SE, Davis MD&DeMets DL (1988): Glycosylated haemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260: 2864-2871.
15. Klein R, Klein BEK, Moss SE, Davis MD&DeMets DL (1989): Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 149: 2427-2432.
16. Klein R, Moss SE&Klein BEK (1993): Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 100: 1140-1146.
17. Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ&Orchard TJ (1995): The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications 9: 140-148.
18. Lövestam-Adrian M, Agardh C-D, Torffvit O&Agardh E (2001): Diabetic retinopathy, visual acuity and medical risk indicators. A continuous 10-year follow-up study in type 1 diabetic patients under routine care. J Diabetes Complications 15: 287-294.
19. Porta M, Tomalino MG, Santoro F et al. (1995): Diabetic retinopathy as a cause of blindness in the province of Turin, Northwest Italy, in 1967-91. Diabetic Med 12: 355-361.
20. Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H&Parving HH (1998): Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 21: 2007-2015.
21. Trautner C, Icks A, Haastert B, Plum B&Berger M (1997): Incidence of blindness in relation to diabetes. Diabetes Care 20: 1147-1153.
22. Vander JF, Duker JS, Benson WE, Brown GC, McNamara JA & Rosenstein RB (1991): Longterm stability and visual outcome after favourable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 98 (10): 1575-1579.